LobbyingPartner Therapeutics lobbying by quarter
Partner Therapeutics's latest lobbying report covers Q2 2026, at $185K. The four quarters Q3 2025–Q2 2026 total $740K. Its first report covers Q4 2022; the issues it reports most are Health Issues and Budget/Appropriations.
Partner Therapeutics
- Latest quarter
- $185K
- Q2 2026 · 3 reports
- Last 12 months
- $740K
- Last 4 quarters
- vs last quarter
- 0.0%
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $105K | 2 |
| Q1 2023 | $105K | 2 |
| Q2 2023 | $105K | 2 |
| Q3 2023 | $105K | 2 |
| Q4 2023 | $105K | 2 |
| Q1 2024 | $105K | 2 |
| Q2 2024 | $105K | 2 |
| Q3 2024 | $105K | 2 |
| Q4 2024 | $105K | 2 |
| Q1 2025 | $185K | 3 |
| Q2 2025 | $185K | 3 |
| Q3 2025 | $185K | 3 |
| Q4 2025 | $185K | 3 |
| Q1 2026 | $185K | 3 |
| Q2 2026 | $185K | 3 |
Policy issues the reports name
- Health issues36 reports
- Budget and appropriations15 reports
- Defense4 reports
A report that names several issues counts once for each.
Who was lobbied
- SENATE36 reports
- HOUSE OF REPRESENTATIVES21 reports
- White House Office16 reports
- Health & Human Services, Dept of (HHS)15 reports
- State, Dept of (DOS)7 reports
- Defense, Dept of (DOD)2 reports
- Energy, Dept of2 reports
Firms it paid
| Firm | ||
|---|---|---|
| Putalastrategies | $900K | 15 quarters |
| SL Strategies | $675K | 15 quarters |
| CGCN Group | $480K | 6 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| MARY MOODY JOHNSON | U.S. Senate Committee on Health, Education, Labor and Pensions | Q2 2026 |
| MARTHA BEATRICE MILLER | Deputy Director of Scheduling, Sen. Ted Cruz (TX), 2019-2020; Scheduler, Rep. Warren Davidson (OH-08), 2020-2022. | Q2 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 08/17for Q2 | SL Strategies | $45K |
| 07/19for Q2 | CGCN Group | $80K |
| 07/16for Q2 | Putalastrategies | $60K |
| 05/04for Q1 | SL Strategies | $45K |
| 04/20for Q1 | CGCN Group | $80K |
| 04/18for Q1 | Putalastrategies | $60K |
| 01/20for Q4 2025 | SL Strategies | $45K |
| 01/20for Q4 2025 | CGCN Group | $80K |
| 01/18for Q4 2025 | Putalastrategies | $60K |
| 25/11/10for Q3 2025 | SL Strategies | $45K |
| 25/10/20for Q3 2025 | CGCN Group | $80K |
| 25/10/18for Q3 2025 | Putalastrategies | $60K |
| 25/07/22for Q2 2025 | SL Strategies | $45K |
| 25/07/21for Q2 2025 | CGCN Group | $80K |
| 25/07/20for Q2 2025 | Putalastrategies | $60K |
| 25/04/21for Q1 2025 | SL Strategies | $45K |
| 25/04/21for Q1 2025 | CGCN Group | $80K |
| 25/04/18for Q1 2025 | Putalastrategies | $60K |
| 25/02/20for Q4 2024 | SL Strategies | $45K |
| 25/02/06for Q1 2025 | CGCN Group | Under $5,000 |